[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 6, Issue 2 (6-2016) ::
Iran J Ped Hematol Oncol 2016, 6(2): 129-135 Back to browse issues page
Prognostic Value of BAALC Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review
Hossein Ayatollahi Dr, Maliheh Hasheminezhad Dr, Arezoo Shojaiee Mrs, Mohammad Hadi Sadeghian Mr, Ehsan Yazdandoust Mr, Maryam Sheikhi Mrs , Sepideh Shakeri Mrs, Seyede Fatemeh Sams
Abstract:   (1959 Views)

Background: Acute myeloid leukemia (AML) is a malignant disorder involving blood cells, characterized by obstructed or distorted differentiation of hematopoietic stem cells. In cytogenetically normal AML (CN AML), molecular abnormalities in NPM, FLT3, CEBPA, and BAALC genes are observed. Initially, high BAALC (Brain and Acute Leukemia Cytoplasmic gene) expression was introduced in a study on AML cases with trisomy 8. The present systematic review aimed to determine the prognostic value of BAALC expression in CN-AML patients within the age range of 1 month to 15 years.

Materials and Methods: In this systematic review, scientific databases including PubMed, Scopus, Embase, ISI, and Cochrane Library were searched. All the evaluated retrospective studies focused on the prognostic value of BAALC expression.

Results: Overall, BAALC expression was reported in 30-60% of AML patients (mean=45%). High expression of BAALC gene was reported in M0, M1, and M2 subtypes of pediatric AML. In only one study, in addition to these subtypes, M4 was also reported (12.5% of cases).

Conclusion: This systematic review resulted in a significant association between high BAALC expression and poor response to chemotherapy in pediatric AML. However, OS (Overall Survival) and EFS (Event - Free Survival) findings were contradictory, relapse and death increase in the presence of high BAALC expression. Therefore, BAALC expression could be considered as a clinical prognostic marker for the treatment of AML patients. Further efficient prognostic indicators should be identified in order to gather information about therapeutic strategies for AML and risk analysis in these patients.

Keywords: BAALC, Expression, Pediatric AML and Prognosis.
Full-Text [PDF 165 kb]   (641 Downloads)    
Type of Study: Research | Subject: Special
Received: 2016/05/26 | Accepted: 2016/05/26 | Published: 2016/05/26
Add your comments about this article
Your username or Email:

Write the security code in the box >

XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ayatollahi H, Hasheminezhad M, Shojaiee A, Sadeghian M H, Yazdandoust E, Sheikhi M, et al . Prognostic Value of BAALC Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review. Iran J Ped Hematol Oncol. 2016; 6 (2) :129-135
URL: http://ijpho.ssu.ac.ir/article-1-251-en.html

Volume 6, Issue 2 (6-2016) Back to browse issues page
Iranian Journal of Pediatric Hematology and Oncology
Persian site map - English site map - Created in 0.22 seconds with 31 queries by YEKTAWEB 3647